![Inge Lues](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Inge Lues worked as Vice President-Global Drug Discovery at Merck KGaA in 2007.
From 2008 to 2018, Lues worked at Vivoryon Therapeutics NV, where she held the position of Chief Development Officer from 2013 to 2018.
Precedenti posizioni note di Inge Lues
| Società | Posizione | Fine |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Direttore Tecnico/Scientifico/R&S | 31/10/2018 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2007 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
11
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
